B. Braun SeQuent SCB Sirolimus coated Rapid Exchange PTCA Balloon Catheter - HSA Registration DE0509168
Access comprehensive regulatory information for B. Braun SeQuent SCB Sirolimus coated Rapid Exchange PTCA Balloon Catheter in the Singapore medical device market through Pure Global AI's free database. This CLASS COM medical device is registered under HSA registration number DE0509168 and owned by B. Braun Melsungen AG. The device was registered on April 15, 2024.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The SeQuent SCB is a PTCA balloon catheter is intended to treat occlusive arterial disease. The SeQuent® SCB is designed to improve the lumen diameter and to reduce restenosis in native artery lesions. It is indicated for: - De-novo lesions (primary use in the case of stenoses or occlusions) including small vessels (small vessel disease – SVD) - Restenosis after balloon or stent-PTCA - Acute or impending vascular occlusion